SynthesisJournal of managed care & specialty pharmacy2020

The Effectiveness and Value of Deflazacort and Exon-Skipping Therapies for the Management of Duchenne Muscular Dystrophy.

Foluso Agboola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.